O’Brien, A. and Williams, R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008; 134 1729 – 1740.
Henkel, A.S. and Buchman, A.L. Nutritional support in patients with chronic liver disease. Nature Clinical Practice. Gastroenterology and Hepatology 2006.
Achord, JL. Malnutrition and the role of nutritional support in alcoholic liver disease. Am J Gastroenterol, 1987 Jan;82(1):1-7.
Kulig, G. Nutritional therapy in decompensated liver cirrhosis. Przegl Lek. 2000;57(6):346-8.
Food Standards Agency. http://www.eatwell.gov.uk/healthydiet/fss
Johnson, AG. Trigger, DR. Oxford University Press. Liver disease and Gallstones the facts.1987.
De Alwis, NMW. Day, CP. Non-alcoholic fatty liver disease: The mist gradually clears. Journal of Hepatology 2008;46:S104 – S112.
Clinical Knowledge Summaries – Alcoholic liver disease.
Collier, JD et al. Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 2002; 50 Suppl (1): i1-i9.
Clinical Knowledge Summaries – Obesity.
Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 2006 Oct;45(4):600-6.
Hart, C L et al. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010; 340:c1240.
Charlton, MR. Pockros, PJ. Harrison, SA. Impact of obesity on chronic hepatitis C. Hepatology, 2006 Jun; 43(6):1177-86.
Ortiz, V. Et al. Contribution of obesity to hepatitis C –related fibrosis progression. Am J Gasteroenterol. 2002 Sep;97(9):2408-14.
Department of health. At least five a week. 2004 Apr. Gateway ref: 2389.
National Obesity Observatory. Obesity and ethnicity. January 2011.
Plauth, M., et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clinical Nutrition 1997 16:43-55.
Map of medicine: http://healthguides.mapofmedicine.com/choices/map/alcoholic_liver_disease_ald_1.html
NICE Alcohol use disorders: diagnosis and clinical management of alcohol-related physical complications Clinical Guideline 100.
European Association for the Study of the Liver. EASL clinical practice guidelines on HFE Hemochromatosis. J Hepatol 2010 doi:10.1016.
Hallberg, L. Et al. Calcium and iron absorption: mechanism of action and nutritional importance. Eur J Clin Nutr. 1992 ,ay;45(5):317-27.
Gabrielli, GB. De Sandre, G. Excessive tea consumption can inhibit the efficacy of oral iron treatment in iron-deficiency anemia. Haematologica, 1995 Nov-Dec;80(6):518-20.
SACN (Scientific Advisory Committee on Nutrition) Iron and Health 2010.
British National Formulary. 2008, Sept;56(9.6.2)531.
Clinical Knowledge Summaries – Gilbert’s syndrome.
Kashani, A. Et al. Fluid retention in cirrhosis: pathophysiology and management. QJM, 2008 Feb;101(2):71-85.
Moore, K P and Aithal. G P Guidelines on the management of ascites in cirrhosis. Gut 2006;55(Suppl VI):vi1–vi12. doi: 10.1136/gut.2006.099580.
Palmer, MD. Guide of Hepatitis and Liver Disease. Penguin Putnam, 2004.
Soulsby, C. T. and Morgan, M. Y. Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom BMJ 1999: 318 1391.
Plauth et al. ESPEN guidelines on enteral nutrition: liver disease Clinical Nutrition 2006 25:285-294.
The Royal Marsden NHS Foundation Trust. Eating well when you have cancer.
Ohnishi K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastro 1996;91:1374-1379.
Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108–111.
Masterton, GS. Hayes, PC. Coffee and the liver: a potential treatment for liver disease? Eur Journal of Gastroenterology and Hepatology, 2010;22:1277-1283.
Gomaa, AI. et al. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterology, 2008 Jul;14(27):4300-4308.
Jin, X. Zheng, RH. Li, YM. Green tea consumption and liver disease: a systematic review. Liver Int, 2008 Aug;28(7):990-6.
Kobayashi H, et al. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine 2010 17:197-202.
Stickel F, Schuppan D Herbal medicine in the treatment of liver diseases Dig. Liver Dis. 2006;39:293-304.
DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use.
National Centre for Complementary and Alternative Medicine (NCCAM). Milk thistle. July 2010; D285.
Mulrow C,et al. Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects Agency for Healthcare Research and Quality. Evidence Report/Technology Assessment; 212000 .